These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 8552619)

  • 1. A Schistosoma mansoni fatty acid-binding protein, Sm14, is the potential basis of a dual-purpose anti-helminth vaccine.
    Tendler M; Brito CA; Vilar MM; Serra-Freire N; Diogo CM; Almeida MS; Delbem AC; Da Silva JF; Savino W; Garratt RC; Katz N; Simpson AS
    Proc Natl Acad Sci U S A; 1996 Jan; 93(1):269-73. PubMed ID: 8552619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination against schistosomiasis and fascioliasis with the new recombinant antigen Sm14: potential basis of a multi-valent anti-helminth vaccine?
    Tendler M; Vilar MM; Brito CA; Freire NM; Katz N; Simpson A
    Mem Inst Oswaldo Cruz; 1995; 90(2):255-6. PubMed ID: 8531667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination against Fasciola hepatica infection using a Schistosoma mansoni defined recombinant antigen, Sm14.
    Almeida MS; Torloni H; Lee-Ho P; Vilar MM; Thaumaturgo N; Simpson AJ; Tendler M
    Parasite Immunol; 2003 Mar; 25(3):135-7. PubMed ID: 12911521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of purified 12 kDa and recombinant 15 kDa Fasciola hepatica antigens related to a Schistosoma mansoni fatty acid binding protein.
    Hillyer GV
    Mem Inst Oswaldo Cruz; 1995; 90(2):249-53. PubMed ID: 8531666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary analysis of Sm14 in distinct fractions of Schistosoma mansoni adult worm extract.
    Thaumaturgo N; Vilar MM; Diogo CM; Edelenyi R; Tendler M
    Mem Inst Oswaldo Cruz; 2001; 96 Suppl():79-83. PubMed ID: 11586430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene structure and M20T polymorphism of the Schistosoma mansoni Sm14 fatty acid-binding protein. Molecular, functioanl, and immunoprotection analysis.
    Ramos CR; Figueredo RC; Pertinhez TA; Vilar MM; do Nascimento AL; Tendler M; Raw I; Spisni A; Ho PL
    J Biol Chem; 2003 Apr; 278(15):12745-51. PubMed ID: 12551912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human T cell epitope mapping of the Schistosoma mansoni 14-kDa fatty acid-binding protein using cells from patients living in areas endemic for schistosomiasis.
    Fonseca CT; Cunha-Neto E; Goldberg AC; Kalil J; de Jesus AR; Carvalho EM; Correa-Oliveira R; Oliveira SC
    Microbes Infect; 2005 Feb; 7(2):204-12. PubMed ID: 15725385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of the two schistosomal antigens Sm14 and Sm29 elicits significant protection against experimental Schistosoma mansoni infection.
    Ewaisha RE; Bahey-El-Din M; Mossallam SF; Amer EI; Aboushleib HM; Khalil AM
    Exp Parasitol; 2014 Oct; 145():51-60. PubMed ID: 25092439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability improvement of the fatty acid binding protein Sm14 from S. mansoni by Cys replacement: structural and functional characterization of a vaccine candidate.
    Ramos CR; Spisni A; Oyama S; Sforça ML; Ramos HR; Vilar MM; Alves AC; Figueredo RC; Tendler M; Zanchin NI; Pertinhez TA; Ho PL
    Biochim Biophys Acta; 2009 Apr; 1794(4):655-62. PubMed ID: 19150418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The biotechnology-value chain: development of Sm14 as a schistosomiasis vaccine.
    Tendler M; Simpson AJ
    Acta Trop; 2008; 108(2-3):263-6. PubMed ID: 18834847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fasciola hepatica: molecular cloning, nucleotide sequence, and expression of a gene encoding a polypeptide homologous to a Schistosoma mansoni fatty acid-binding protein.
    Rodríguez-Pérez J; Rodríguez-Medina JR; García-Blanco MA; Hillyer GV
    Exp Parasitol; 1992 Jun; 74(4):400-7. PubMed ID: 1592092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful vaccination against murine Schistosoma mansoni infection with a purified 12 Kd Fasciola hepatica cross-reactive antigen.
    Hillyer GV; García Rosa MI; Alicea H; Hernandez A
    Am J Trop Med Hyg; 1988 Jan; 38(1):103-10. PubMed ID: 3124643
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Morais SB; Figueiredo BC; Assis NRG; Homan J; Mambelli FS; Bicalho RM; Souza C; Martins VP; Pinheiro CS; Oliveira SC
    Front Immunol; 2018; 9():1762. PubMed ID: 30105029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against Schistosoma mansoni infection using a Fasciola hepatica-derived fatty acid binding protein from different delivery systems.
    Vicente B; López-Abán J; Rojas-Caraballo J; del Olmo E; Fernández-Soto P; Muro A
    Parasit Vectors; 2016 Apr; 9():216. PubMed ID: 27090442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping of B-cell epitopes on a novel 11.5-kilodalton Fasciola hepatica-Schistosoma mansoni cross-reactive antigen belonging to a member of the F. hepatica saposin-like protein family.
    Torres D; Espino AM
    Infect Immun; 2006 Aug; 74(8):4932-8. PubMed ID: 16861685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. r-Sm14 - pRSETA efficacy in experimental animals.
    Ramos CR; Vilar MM; Nascimento AL; Ho PL; Thaumaturgo N; Edelenyi R; Almeida M; Dias WO; Diogo CM; Tendler M
    Mem Inst Oswaldo Cruz; 2001; 96 Suppl():131-5. PubMed ID: 11586438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased immunogenicity and protection of recombinant Sm14 antigens by heat-killed Cutibacterium acnes in BALB/c mice infected with Schistosoma mansoni.
    Lam HYP; Huang SP; Liang TR; Wu WJ; Cheng PC; Chang KC; Peng SY
    Parasitol Int; 2022 Feb; 86():102446. PubMed ID: 34481947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant Mycobacterium bovis BCG expressing the Sm14 antigen of Schistosoma mansoni protects mice from cercarial challenge.
    Varaldo PB; Leite LC; Dias WO; Miyaji EN; Torres FI; Gebara VC; Armôa GR; Campos AS; Matos DC; Winter N; Gicquel B; Vilar MM; McFadden J; Almeida MS; Tendler M; McIntosh D
    Infect Immun; 2004 Jun; 72(6):3336-43. PubMed ID: 15155638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the use of C-terminal part of the Schistosoma mansoni 200kDa tegumental protein in schistosomiasis diagnosis and vaccine formulation.
    Carvalho GB; Pacífico LG; Pimenta DL; Siqueira LM; Teixeira-Carvalho A; Coelho PM; Pinheiro Cda S; Fujiwara RT; Oliveira SC; Fonseca CT
    Exp Parasitol; 2014 Apr; 139():24-32. PubMed ID: 24560833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and partial characterization of an antigen shared between Schistosoma mansoni, Fasciola hepatica, and Biomphalaria glabrata.
    Rasmussen KR; Hillyer GV; Kemp WM
    J Parasitol; 1985 Dec; 71(6):792-8. PubMed ID: 2419536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.